Clinical trial
Molecular, Genomic, Cellular, and Functional Characterization of Blood Specimens From Former U.S. Service Members With Prior Burn Pit Exposure
NCT07562243 is registered in ClinicalTrials.gov with Creative Medical Technology Holdings Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular, Genomic, Cellular, and Functional Characterization of Blood Specimens From Former U.S. Service Members With Prior Burn Pit Exposure
- Lead sponsor
- Creative Medical Technology Holdings Inc
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 1, 2026
- Completion date
- December 31, 2031
- Enrollment
- 1,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
airborne hazard exposure, biomarkers, burn pit exposure, deployment-related toxic exposure, immune dysfunction, respiratory symptoms, veteran health